U.S. Markets closed

Targeted Medical Pharma, Inc. (TRGM)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.011-0.00 (-26.67%)
At close: 3:33PM EDT
People also watch
FPMIAOLSULURSURPVGLS
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201512/31/201412/31/2013
Total Revenue5,260.9417,112.3599,555.562
Cost of Revenue2,095.6812,216.5282,989.305
Gross Profit3,165.264,895.8316,566.257
Operating Expenses
Research Development12.317158.37228.605
Selling General and Administrative5,182.7167,348.41210,178.598
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-2,029.773-2,610.951-3,840.946
Income from Continuing Operations
Total Other Income/Expenses Net136.14611.059159.341
Earnings Before Interest and Taxes-1,893.627-2,599.892-3,670.716
Interest Expense1,173.5651,229.2891,229.289
Income Before Tax-3,067.192-3,829.181-3,670.716
Income Tax Expense-65.8285,666.902
Minority Interest-23.382-23.382-23.382
Net Income From Continuing Ops-3,043.81-3,895.009-9,337.618
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-3,043.81-3,895.009-9,337.618
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-3,043.81-3,895.009-9,337.618